Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

México Noticias Noticias

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
México Últimas Noticias,México Titulares
  • 📰 CNBC
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 72%

Bristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.

Bristol Myers Squibb reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates.Bristol Myers Squibb

The drugmaker said that decline was due to lower sales of Revlimid, which generated $1.43 billion for the quarter. Bristol Myers has been under pressure to launch or acquire new drug products as Revlimid – and eventually, otherRevlimid sales, which fell 41% from the third quarter of 2022, also dropped due to an increase in patients receiving the drug at no cost through the company's patient assistance foundation, Bristol Myers said.

The company narrowed its full-year adjusted earnings outlook to $7.50 to $7.65 per share, from a previous forecast of $7.35 to $7.65 a share.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

CNBC /  🏆 12. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Bristol-Myers Squibb earnings top estimatesBristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »

Bristol Myers says it needs another year to hit target for new drugsBristol Myers says it needs another year to hit target for new drugsDrugmaker Bristol Myers Squibb (BMY.N) on Thursday pushed back by a year the time frame for its current new-product portfolio to hit $10 billion in sales as the ramp-up of new drugs including anemia treatment Reblozyl, psoriasis drug Sotyktu, and multiple sclerosis drug Zeposia takes longer than expected.
Leer más »

Turning Michael Myers Into a Supernatural Cult Monster Made Him Less ScaryTurning Michael Myers Into a Supernatural Cult Monster Made Him Less ScaryHalloween: The Curse of Michael Myers introduces the Cult of Thorn and tries to give the iconic killer an unneeded backstory.
Leer más »

De La Ghetto, Bryant Myers, Luar La L & YOVNGCHIMI Debut on Hot 100De La Ghetto, Bryant Myers, Luar La L & YOVNGCHIMI Debut on Hot 100All 21 songs from Bad Bunny’s new LP chart on the Hot 100.
Leer más »

Longtime fisherman reflects on his career in Bristol BayLongtime fisherman reflects on his career in Bristol BayDan Barr is eighty-one and a half years old. He fished Bristol Bay for just about half his life.
Leer más »

NECA's Tom Atkins Halloween III: Season of the Witch Figure Is Boozy PerfectionNECA's Tom Atkins Halloween III: Season of the Witch Figure Is Boozy PerfectionDr. Dan Challis, as well as a new Michael Myers and Freddy Krueger, highlight the toy company's spooky new drop.
Leer más »



Render Time: 2025-02-28 14:52:47